Stage III Breast Cancer Recruiting Phase 3 Trials for Mitometh (DB12117)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02445391Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant ChemotherapyTreatment